<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/87AED907-EEFA-4677-BDB2-EAE1CFDC9F5A"><gtr:id>87AED907-EEFA-4677-BDB2-EAE1CFDC9F5A</gtr:id><gtr:name>University of Sao Paolo</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D7F6813-A83D-41F3-A308-3B162C7DFCA1"><gtr:id>5D7F6813-A83D-41F3-A308-3B162C7DFCA1</gtr:id><gtr:name>National Brain Research Centre, India</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1EC5A569-85E9-44B3-AD1F-049F1003C9C6"><gtr:id>1EC5A569-85E9-44B3-AD1F-049F1003C9C6</gtr:id><gtr:name>University of Barcelona</gtr:name><gtr:address><gtr:line1>Universidad de Barcelona</gtr:line1><gtr:line2>Av Diagonal 647</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/87AED907-EEFA-4677-BDB2-EAE1CFDC9F5A"><gtr:id>87AED907-EEFA-4677-BDB2-EAE1CFDC9F5A</gtr:id><gtr:name>University of Sao Paolo</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D7F6813-A83D-41F3-A308-3B162C7DFCA1"><gtr:id>5D7F6813-A83D-41F3-A308-3B162C7DFCA1</gtr:id><gtr:name>National Brain Research Centre, India</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1EC5A569-85E9-44B3-AD1F-049F1003C9C6"><gtr:id>1EC5A569-85E9-44B3-AD1F-049F1003C9C6</gtr:id><gtr:name>University of Barcelona</gtr:name><gtr:address><gtr:line1>Universidad de Barcelona</gtr:line1><gtr:line2>Av Diagonal 647</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2E163E91-6FA0-40D9-998D-8E2217FCE635"><gtr:id>2E163E91-6FA0-40D9-998D-8E2217FCE635</gtr:id><gtr:firstName>Sagnik</gtr:firstName><gtr:surname>Bhattacharyya</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501775"><gtr:id>5CB218F1-DD59-407E-87B9-BEA994CF098C</gtr:id><gtr:title>Neurocognitive and genetic basis of the effects of cannabis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501775</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>BACKGROUND: Although multiple lines of evidence suggest a link between cannabis use and psychotic symptoms, there is a marked variability in the effects of the drug across individuals, and most people who use cannabis do not develop schizophrenia. This variability in the effects of cannabis may reflect differences in genetic factors, particulary in genotypes that confer vulnerability to schizophrenia.
OBJECTIVES: I will investigate this by studying three groups of individuals who vary in their vulnerability to develop psychosis. I will examine the effect of the experimental adminstration of tetrahydrocannabinol (THC; the main active ingredient of cannabis) on their mental state, cognitive function and brain activation. 
DESIGN &amp;amp; METHODOLOGY: Subjects: 35 first-degree relatives of patients with schizophrenia, 35 healthy volunteers with high levels of schizotypal features and 35 healthy volunteers with no family history of schizophrenia and low levels of schizotypal features. All subjects will have used cannabis at least once but less than 25 times in their lifetime. They will be given a small safe oral dose of either THC or placebo on 2 separate occasions. The symptomatic effects will be assessed using psychopathological rating scales, and subjects will perform 5 cognitive tasks that engage processes implicated in psychosis and are known to be affected by cannabis use. In a subset of each group 3 of the cognitive tasks will be performed while the subjects are undergoing functional MRI. All subjects will be genotyped for the main genes implicated in schizophrenia (Dysbindin, DISC-I, Neuregulin 1, G72, COMT and D-AminoAcid Oxidase). Pilot work has established the feasibility, power and safety of the methods. At the doses used, when THC does have psychological effects these are relatively mild and do not lasted more than a few hours. As further precautions, only subjects who have used cannabis before with no adverse effects can participate, and the relatives will be beyond the age of risk for schizophrenia. Hypothesis: The effects of THC on symptoms, cognitive performance and brain activation will depend on the individual?s genetic vulnerability to schizophrenia.
SCIENTIFIC &amp;amp; MEDICAL OPPORTUNITIES: This study should clarify how cannabis acts on the brain to produce its effects, and establish if the variability in the sensitivity to its effects is genetically determined.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>213874</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Barcelona (UB)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Collaboration with Dr Rocio Martin-Santos at the University of Barcelona</gtr:description><gtr:id>6A1BA4D5-88ED-4F3D-81AF-C9058DB1C801</gtr:id><gtr:impact>PMID: 23829359, 23390554, 23352282, 23311613</gtr:impact><gtr:outcomeId>SLUnvrXjEUG-1</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects</gtr:partnerContribution><gtr:piContribution>Dr Rocio Martin-Santos</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Brain Research Centre, India</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>Collaboration with NBRC, India</gtr:description><gtr:id>6BE7B917-7011-4B3B-A46F-E0315A1AE6E5</gtr:id><gtr:impact>No outputs yet</gtr:impact><gtr:outcomeId>56e03278ec2315.11848072-1</gtr:outcomeId><gtr:partnerContribution>Contributed to the funding application and identified the postdoctoral fellow.</gtr:partnerContribution><gtr:piContribution>Applied for funding to host a postdoctoral fellow funded by the Newton International fellowship scheme of the Academy of Medical Sciences, UK.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>Collaboration with Imperial College London</gtr:description><gtr:id>159A3690-4F16-49F1-A804-6CF8B6E72FFC</gtr:id><gtr:impact>Pubmed ID:22042229, 21741803, 21150914, 20652859,19924114, 21035785</gtr:impact><gtr:outcomeId>suMUqjj2ZXM-1</gtr:outcomeId><gtr:partnerContribution>Intellectual</gtr:partnerContribution><gtr:piContribution>Intellectual</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sao Paulo</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:department>Department of Neurology, Psychiatry and Medical Psychology</gtr:department><gtr:description>Collaboration with researchers at University of Sao Paolo</gtr:description><gtr:id>A76382A6-7018-4D90-97A0-45956EE95F66</gtr:id><gtr:impact>Pubmed ID:20829306, 19924114, 19775500, 19693792,19349314, 19124693, 18589404</gtr:impact><gtr:outcomeId>ipZpjwBJMW1-1</gtr:outcomeId><gtr:partnerContribution>Intellectual contributions</gtr:partnerContribution><gtr:piContribution>Intellectual</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Encyclopedia Britannica Blog</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>63D7EFC3-C251-4210-931B-D335E660763F</gtr:id><gtr:impact>My work has led to a more nuanced understanding of the public health implications of cannabis use, based on robust experimental evidence of its effects on brain function, different individual vulnerability and different and often opposing effects of different cannabinoids, some of which may in fact have therapeutic benefits.

The invitation to write for the online blog for Encyclopedia Britannica was in relation to the vote that was due in 2010 on legalization of cannabis in California, USA.</gtr:impact><gtr:outcomeId>kEVTkLwGJPJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.britannica.com/blogs/author/sbhattacharyya/),</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview to a journalist</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4DAEB4A4-926E-4C1F-AE0E-2DA248495025</gtr:id><gtr:impact>This resulted in articles published in &amp;quot;Weed world&amp;quot; and Canada's &amp;quot;treating Yourself Magazine&amp;quot; (http://richardshrubb.co.uk/weed%20word%20schizophrenia.pdf)

Contribution to public understanding regarding the complexities in the association between cannabis use and psychosis.</gtr:impact><gtr:outcomeId>P4ojtuPTWaf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://treatingyourself.com/images/issues/pdfs/issue37.pdf</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HORIZON</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>986EF93F-47CD-4ACE-8175-1D14E6D2CBD1</gtr:id><gtr:impact>Featured in the HORIZON program. Has also been interviewed for a documentary for the DISCOVERY channel

Not applicable</gtr:impact><gtr:outcomeId>7D4EBC244F6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ECNP Fellowship</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>European College of Neuropsychopharmacology (ECNP)</gtr:fundingOrg><gtr:id>3F8F515D-1893-4185-9291-CEE12F7B2B96</gtr:id><gtr:outcomeId>hvLBDMM8La60</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Brain A Journal of Neurology</gtr:department><gtr:description>Brain Travel Award</gtr:description><gtr:end>2009-11-02</gtr:end><gtr:fundingOrg>Oxford University Press</gtr:fundingOrg><gtr:id>6D16FB76-1084-435C-8218-C9AC3DA9250C</gtr:id><gtr:outcomeId>KhwBBqB7Qtx0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Young Psychiatrist Scholarship</gtr:description><gtr:end>2008-04-02</gtr:end><gtr:fundingOrg>European Psychiatric Association (EPA)</gtr:fundingOrg><gtr:id>14AF6047-F058-45F9-90B7-2A97BCCD0D0B</gtr:id><gtr:outcomeId>nc1Tyew3AX10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>641D0B0C-8CD3-4A18-BB0B-3F8F2FFC5930</gtr:id><gtr:title>Neuroimaging evidence for cannabinoid modulation of cognition and affect in man.</gtr:title><gtr:parentPublicationTitle>Frontiers in behavioral neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1662-5153</gtr:issn><gtr:outcomeId>pm_14601_21_22654743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1270C6A9-18F5-474E-91AB-249E6D297AB8</gtr:id><gtr:title>Anti-depressive therapies after heart transplantation.</gtr:title><gtr:parentPublicationTitle>The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d291d20ff6b7d57155002e6583fb3ce2"><gtr:id>d291d20ff6b7d57155002e6583fb3ce2</gtr:id><gtr:otherNames>Fusar-Poli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1053-2498</gtr:issn><gtr:outcomeId>58b4447e2ecdb9.10837349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E5AF1B9-9BFF-480F-BEE1-14042D470725</gtr:id><gtr:title>Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5623026c7b4b72187698f4688c48b355"><gtr:id>5623026c7b4b72187698f4688c48b355</gtr:id><gtr:otherNames>Velayudhan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>pm_540e194e1947d69d9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C33F6192-0B46-4DB8-9187-F0E346EC1BAC</gtr:id><gtr:title>Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>54622f7ba16444.77185315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64914375-60B1-4F15-8BF3-ABB050534AE1</gtr:id><gtr:title>Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>4103E423523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCABD8BD-83C8-4E27-8ECB-821DBE2E30C0</gtr:id><gtr:title>Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dec4ddbccec588d8be966d99ba480b61"><gtr:id>dec4ddbccec588d8be966d99ba480b61</gtr:id><gtr:otherNames>Batalla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14601_21_23390554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3420B19D-0BBD-49B9-96D1-817FA26D28DF</gtr:id><gtr:title>Alterations in white matter evident before the onset of psychosis.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0409bff75350c41e79a5bb5366263fa3"><gtr:id>0409bff75350c41e79a5bb5366263fa3</gtr:id><gtr:otherNames>Carletti F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn><gtr:outcomeId>pm_14601_21_22472474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C120A6F-7EF2-4666-9E99-7C86AE569DB2</gtr:id><gtr:title>Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff316446e79dc95b484b91102b4074b"><gtr:id>fff316446e79dc95b484b91102b4074b</gtr:id><gtr:otherNames>Crippa JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>58b4447bd6ad77.49112584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51D82055-D68A-45B6-A932-0AB780122ACE</gtr:id><gtr:title>Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d36183be0cf83546985fd8debdab660"><gtr:id>9d36183be0cf83546985fd8debdab660</gtr:id><gtr:otherNames>Winton-Brown TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>545b862a9905a1.39071899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC5A67A8-4FB8-4214-80B1-ADC825A5D1EC</gtr:id><gtr:title>Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b16f100f8066b8f5707f55d8154c421b"><gtr:id>b16f100f8066b8f5707f55d8154c421b</gtr:id><gtr:otherNames>Borgwardt SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>58b4447da63c60.12844474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4D7A9D5-1D35-4B42-A2AC-69B67249EA0E</gtr:id><gtr:title>Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dec4ddbccec588d8be966d99ba480b61"><gtr:id>dec4ddbccec588d8be966d99ba480b61</gtr:id><gtr:otherNames>Batalla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>pm_14601_21_23311613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC5C84A3-A757-4A60-9B5F-41189C162BE7</gtr:id><gtr:title>Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dec4ddbccec588d8be966d99ba480b61"><gtr:id>dec4ddbccec588d8be966d99ba480b61</gtr:id><gtr:otherNames>Batalla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>pm_540e146e146e3a09b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B0A6A60-4D8A-4AA0-8762-414D1733FF82</gtr:id><gtr:title>Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>D0BAA177AAC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D78D2784-61BA-422A-A37D-EC3777397B5E</gtr:id><gtr:title>Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>58b4447d1ec630.70493735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDE415D3-E8DC-4A8C-A1E6-7A04C39DA120</gtr:id><gtr:title>Neuroimaging in cannabis use: a systematic review of the literature.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d13319ab37d14175ca1c93329d215844"><gtr:id>d13319ab37d14175ca1c93329d215844</gtr:id><gtr:otherNames>Mart?n-Santos R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>6A726FA3192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91F67DF4-74C2-4340-82A9-A75F00710DAB</gtr:id><gtr:title>The effects of cannabis use on salience attribution: a systematic review.</gtr:title><gtr:parentPublicationTitle>Acta neuropsychiatrica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc2605fdf7c69ca7d4fd21f6ed02c4f9"><gtr:id>bc2605fdf7c69ca7d4fd21f6ed02c4f9</gtr:id><gtr:otherNames>Wijayendran SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0924-2708</gtr:issn><gtr:outcomeId>58b44479c355f0.31467096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB52CD07-BE2E-422D-A041-43D956A41ACC</gtr:id><gtr:title>Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis.</gtr:title><gtr:parentPublicationTitle>Neuroscience and biobehavioral reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cdfcb9f0434c41fccd9cd7cf822342e"><gtr:id>2cdfcb9f0434c41fccd9cd7cf822342e</gtr:id><gtr:otherNames>Kambeitz JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0149-7634</gtr:issn><gtr:outcomeId>pm_14601_21_22813992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01FD753A-048C-4092-A6AD-D9120CA7E98C</gtr:id><gtr:title>Road work on memory lane--functional and structural alterations to the learning and memory circuit in adults born very preterm.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcbf676aa5d235f40dd33be3a5afb780"><gtr:id>fcbf676aa5d235f40dd33be3a5afb780</gtr:id><gtr:otherNames>Salvan P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>545b862abeeb87.87088309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C778C557-549C-487F-8A33-F8181773A05B</gtr:id><gtr:title>Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ?9-tetrahydrocannabinol (THC).</gtr:title><gtr:parentPublicationTitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a4b4fe60da7aac199aa2977416b6eef"><gtr:id>0a4b4fe60da7aac199aa2977416b6eef</gtr:id><gtr:otherNames>Bossong MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0278-5846</gtr:issn><gtr:outcomeId>58b4447ae77911.24102207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7144F05-8459-4746-BC87-EACAC71930E8</gtr:id><gtr:title>Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01239ba02c73c9db62bc80f14607a1ed"><gtr:id>01239ba02c73c9db62bc80f14607a1ed</gtr:id><gtr:otherNames>Martin-Santos R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>pm_14601_21_22716148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDECCE4C-6D64-4F0D-ADBE-B2BDEAB8FDB8</gtr:id><gtr:title>Cannabis and anxiety: a critical review of the evidence.</gtr:title><gtr:parentPublicationTitle>Human psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff316446e79dc95b484b91102b4074b"><gtr:id>fff316446e79dc95b484b91102b4074b</gtr:id><gtr:otherNames>Crippa JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-6222</gtr:issn><gtr:outcomeId>58b4447ca6c2c3.75091856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18A27E04-20CB-46C5-A9A5-83375017403F</gtr:id><gtr:title>Cannabis affects people differently: inter-subject variation in the psychotogenic effects of ?9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abd3c1204c86db4367cf308ab6266faf"><gtr:id>abd3c1204c86db4367cf308ab6266faf</gtr:id><gtr:otherNames>Atakan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>pm_14601_21_23020923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88F97484-3DBA-4CAB-9030-9334D548C868</gtr:id><gtr:title>Cannabis use and transition to psychosis in people at ultra-high risk.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1fc6c7dc741f17d75379b1a09057d24"><gtr:id>e1fc6c7dc741f17d75379b1a09057d24</gtr:id><gtr:otherNames>Valmaggia LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>54622ee2974564.50987346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5691DAD1-C56D-4126-98E4-323B679721AB</gtr:id><gtr:title>Induction of psychosis by ?9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>pm_14601_21_22213786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAAC2F87-E57E-4971-9519-EC48BA8095E0</gtr:id><gtr:title>Cannabinoid modulation of functional connectivity within regions processing attentional salience.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>545b86c70cedc8.07334389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03782780-6645-4E4D-BF12-336256EC8A2B</gtr:id><gtr:title>Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d291d20ff6b7d57155002e6583fb3ce2"><gtr:id>d291d20ff6b7d57155002e6583fb3ce2</gtr:id><gtr:otherNames>Fusar-Poli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>2D22834BC48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AE59ABC-61A4-488F-AB94-3B6526BF9FD2</gtr:id><gtr:title>Interpersonal sensitivity in the at-risk mental state for psychosis.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d678d3f22989b44d649c5c9961f77eae"><gtr:id>d678d3f22989b44d649c5c9961f77eae</gtr:id><gtr:otherNames>Masillo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>pm_14601_21_22225783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AD7D566-EEFB-4E54-916D-FCA6ACDBFF8E</gtr:id><gtr:title>The effect of cannabis use on memory function: an update.</gtr:title><gtr:parentPublicationTitle>Substance abuse and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c7ed158fa94eb59e3b74c1437b782b5"><gtr:id>6c7ed158fa94eb59e3b74c1437b782b5</gtr:id><gtr:otherNames>Schoeler T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1179-8467</gtr:issn><gtr:outcomeId>doi_14601_SAR_S25869</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>451A43CA-9967-4140-9A9D-053E21F87F03</gtr:id><gtr:title>Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of d-9-tetrahydrocannabinol on midbrain and striatal function.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_14601_21_22290123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED7386CB-B4F4-472B-87EA-03F383771CF0</gtr:id><gtr:title>Acute and non-acute effects of cannabis on human memory function: a critical review of neuroimaging studies.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a4b4fe60da7aac199aa2977416b6eef"><gtr:id>0a4b4fe60da7aac199aa2977416b6eef</gtr:id><gtr:otherNames>Bossong MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>pm_540e194e19491c8b1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5B8B770-2D02-43D8-8BFE-AC6E477375FE</gtr:id><gtr:title>Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>58b4447cda4568.08375019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD152404-5F0F-4B03-8469-9EF235388793</gtr:id><gtr:title>Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f919d9d0877818a50c27b63a222b581"><gtr:id>8f919d9d0877818a50c27b63a222b581</gtr:id><gtr:otherNames>Valli I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>58b4447b912755.82657169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>352F90E6-999F-4CAD-BBAB-7CD29F356233</gtr:id><gtr:title>Glutamatergic dysfunction--newer targets for anti-obsessional drugs.</gtr:title><gtr:parentPublicationTitle>Recent patents on CNS drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1574-8898</gtr:issn><gtr:outcomeId>227709A595B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BB80AD4-8F7E-4537-A1BE-70C211FF8832</gtr:id><gtr:title>Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>pm_14601_21_22716136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE9564E6-189D-429D-93A9-BC4539960095</gtr:id><gtr:title>Substance use and regional gray matter volume in individuals at high risk of psychosis.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49b1a2224b337a1dda5d402fdfa5fb51"><gtr:id>49b1a2224b337a1dda5d402fdfa5fb51</gtr:id><gtr:otherNames>Stone JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>58b4447b2132c6.86520489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>511C0511-BE71-4C54-B217-543681CF0D50</gtr:id><gtr:title>Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49b1a2224b337a1dda5d402fdfa5fb51"><gtr:id>49b1a2224b337a1dda5d402fdfa5fb51</gtr:id><gtr:otherNames>Stone JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>dLTQQ5CKAW8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>548D5014-9902-4D1E-BA61-F65341926268</gtr:id><gtr:title>Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/602d06be666e00cab6ec003ca59da89f"><gtr:id>602d06be666e00cab6ec003ca59da89f</gtr:id><gtr:otherNames>Sami MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>5675e65201edf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7189859C-A243-4465-B49E-94E4BC485D86</gtr:id><gtr:title>Disruption of frontal ? coherence by ?9-tetrahydrocannabinol is associated with positive psychotic symptoms.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8518c425eda8de5996a6faf295f0bec"><gtr:id>f8518c425eda8de5996a6faf295f0bec</gtr:id><gtr:otherNames>Morrison PD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>58b4447b586680.22253943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>185A565B-3574-4C43-8EF6-8715B3CC888A</gtr:id><gtr:title>Delta-9-tetrahydrocannabinol disruption of time perception and of self-timed actions.</gtr:title><gtr:parentPublicationTitle>Pharmacopsychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49b1a2224b337a1dda5d402fdfa5fb51"><gtr:id>49b1a2224b337a1dda5d402fdfa5fb51</gtr:id><gtr:otherNames>Stone JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0176-3679</gtr:issn><gtr:outcomeId>ePcVB1Cfvkn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE66BEF7-F66C-4DEE-80B2-FDB9241E1ED1</gtr:id><gtr:title>A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673d1fdb2574f790c05e997d1e07c50b"><gtr:id>673d1fdb2574f790c05e997d1e07c50b</gtr:id><gtr:otherNames>Zuardi AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>pm_14601_21_22716160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5A56ACE-B472-4955-99F3-02DC6B0696EA</gtr:id><gtr:title>Neural compensation in adulthood following very preterm birth demonstrated during a visual paired associates learning task.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b527af0ebc85f99178c08cd94fe843fb"><gtr:id>b527af0ebc85f99178c08cd94fe843fb</gtr:id><gtr:otherNames>Brittain PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn><gtr:outcomeId>54622f7bcc2a97.00784658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03EFEDAC-55A9-4FFD-BF6F-F3E66483E359</gtr:id><gtr:title>Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdb4d0c0fcb035df8e11215ae279d07"><gtr:id>bcdb4d0c0fcb035df8e11215ae279d07</gtr:id><gtr:otherNames>Bhattacharyya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>548856db66cde3.95173327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D1820CD-AB16-427C-B32E-4E6A72FFB665</gtr:id><gtr:title>Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.</gtr:title><gtr:parentPublicationTitle>The international journal of neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d291d20ff6b7d57155002e6583fb3ce2"><gtr:id>d291d20ff6b7d57155002e6583fb3ce2</gtr:id><gtr:otherNames>Fusar-Poli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1461-1457</gtr:issn><gtr:outcomeId>58b4447c24bf89.90223852</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501775</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>